StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
KARE.AT$424.00-0.24%
Fair $424.00+0.0%

KARE.AT

Karelia Tobacco Company Inc.

Consumer Defensive / TobaccoAthens

$424.00

-1.00 (-0.24%)

Fairly Valued+0.0%Fair Value $424.00Fund rank 37/100 · Data gapFallback financials|
SA 64/B
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 23% · confianza 25%

FCF escenarios

weak_data · normalized FCF $88.1M · quality 77.0/100

Data gap 37/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 77/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

64/100

B

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

20/100

SEC 0%

Latest source: yahooPeriods: 5Warnings: 0yahoo: 5
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · KARE.ATLocal privado en este navegador · Karelia Tobacco Company Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.2B

P/E

11.3x

↓

EV/EBITDA

6.3x

↓

ROE

12.1%

↑

Gross Margin

9.7%

↓

Debt/Equity

0.00

↓
52-Week Range$424
$306$434

TradingView lightweight chart

KARE.AT price, volumen y niveles de valoración

Último $424.00Periodo +270.5%
Fair value: $424.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2021–2025 · 4 años de histórico normalizado

Revenue CAGR

+9.0%

FCF CAGR

-0.6%

FCF margin

5.3%

FCF / Net income

0.85x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.67B · net income $103.3M · FCF $88.1M

2021-FY → 2025-FY

Gross margin

9.7%-0.7% pts

Operating margin

8.0%-0.4% pts

Net margin

6.2%-1.2% pts

FCF margin

5.3%-2.3% pts
MetricTTM
2025
2024
2023
2022
2021
Income Statement
Revenue$1.67B$1.67B$1.51B$1.32B$1.27B$1.18B
Net Income$103.3M$103.3M$112.8M$86.8M$85.4M$87.7M
EBITDA$140.3M$140.3M$112.3M$104.9M$119.9M$123.6M
EPS37.4237.4240.8731.4730.9331.77
Gross Margin9.7%9.7%8.8%9.4%10.3%10.4%
Operating Margin8.0%8.0%6.9%7.4%8.1%8.4%
Net Margin6.2%6.2%7.5%6.6%6.7%7.4%
Balance Sheet
Debt/Equity0.000.000.000.000.000.00
Current Ratio4.484.48————
Cash Flow
Free Cash Flow$88.1M$88.1M$89.9M$74.5M$135.4M$90.2M
Returns
ROE12.1%12.1%14.2%12.2%13.0%14.5%
Valuation
P/E11.3411.348.5611.129.579.00
EV/EBITDA6.286.285.947.214.513.79
P/B1.371.371.221.351.241.31
Growth & Yield
Revenue Growth10.7%10.7%13.9%4.6%——
EPS Growth-8.5%-8.5%29.9%1.7%——
Dividend Yield3.4%3.4%————

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

0.2%

fácil

EPS terminal req.

$37.62

Spread vs growth

-8.6%

5Y implied EPS CAGR

4.0%

fácil

EPS terminal req.

$45.52

Spread vs growth

-12.5%

10Y implied EPS CAGR

7.0%

razonable

EPS terminal req.

$73.32

Spread vs growth

-15.4%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +38.5%

Total return

+38.5%

Start / end P/E

7.7x → 11.3x

EPS bridge

40.87 → 37.42

Residual

-4.0%

EPS growth-8.5%
Multiple rerating+47.5%
Dividend+3.4%
Residual / FX / buybacks / cross-term-4.0%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.